Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Liabilities from Discontinued Operations: 2024

Historic Liabilities from Discontinued Operations for Roivant Sciences (ROIV) over the last 1 years, with Mar 2024 value amounting to $433.9 million.

  • Roivant Sciences' Liabilities from Discontinued Operations was N/A to $401.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $401.2 million, marking a year-over-year change of. This contributed to the annual value of $433.9 million for FY2024, which is N/A change from last year.
  • As of FY2024, Roivant Sciences' Liabilities from Discontinued Operations stood at $433.9 million.
  • Roivant Sciences' 5-year Liabilities from Discontinued Operations high stood at $433.9 million for FY2024, and its period low was $433.9 million during FY2024.
  • Moreover, its 1-year median value for Liabilities from Discontinued Operations was $433.9 million (2024), whereas its average is $433.9 million.